A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition
14 auth.
Lars Schiffmann,
M. Brunold,
M. Liwschitz,
V. Goede,
S. Loges,
M. Wroblewski,
A. Quaas,
Hakan Alakus,
D. Stippel,
C. Bruns,
...
M. Hallek,
H. Kashkar,
U. Hacker,
O. Coutelle
|
|
4 |
2017 |
Social Media Posts